home / stock / bctxf / bctxf quote
Last: | $5.95 |
---|---|
Change Percent: | -1.32% |
Open: | $6.018 |
Close: | $5.95 |
High: | $6.018 |
Low: | $5.95 |
Volume: | 2,095 |
Last Trade Date Time: | 02/23/2021 04:53:47 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.95 | $6.018 | $5.95 | $6.018 | $5.95 | 2,095 | 02-23-2021 |
$6.0293 | $6.2 | $6.0293 | $6.3492 | $6.0293 | 2,571 | 02-22-2021 |
$6.1691 | $5.59 | $6.1691 | $6.1691 | $5.59 | 554 | 02-19-2021 |
$5.34 | $5.55 | $5.34 | $5.55 | $5.14 | 1,803 | 02-18-2021 |
$5.47 | $5.23 | $5.47 | $5.47 | $4.9405 | 3,585 | 02-17-2021 |
$5.22 | $4.89 | $5.22 | $5.2841 | $4.89 | 4,389 | 02-16-2021 |
$4.798 | $4.7069 | $4.798 | $4.798 | $4.7069 | 5,672 | 02-15-2021 |
$4.798 | $4.7069 | $4.798 | $4.798 | $4.7069 | 5,672 | 02-12-2021 |
$4.5 | $4.33 | $4.5 | $4.5 | $4.27 | 3,962 | 02-11-2021 |
$4.33 | $4.39 | $4.33 | $4.39 | $4.33 | 1,002 | 02-09-2021 |
$3.9923 | $4.05 | $3.9923 | $4.0707 | $3.9923 | 450 | 02-08-2021 |
$4.03 | $4.1901 | $4.03 | $4.1901 | $4.03 | 1,500 | 02-05-2021 |
$4.67 | $4.29 | $4.67 | $4.67 | $4.29 | 2,199 | 02-03-2021 |
$3.8821 | $3.66999 | $3.8821 | $3.89 | $3.51 | 3,254 | 02-01-2021 |
$4.75 | $4.75 | $4.75 | $4.75 | $4.75 | 142 | 01-28-2021 |
$5.14 | $5.14642 | $5.14 | $5.15 | $5.14 | 420 | 01-27-2021 |
$5.18 | $5.26199 | $5.18 | $5.262 | $5.18 | 2,300 | 01-20-2021 |
$5.5 | $5.5 | $5.5 | $5.5 | $5.5 | 245 | 01-19-2021 |
$5.51 | $5.51 | $5.51 | $5.51 | $5.51 | 866 | 01-18-2021 |
$5.51 | $5.51 | $5.51 | $5.51 | $5.51 | 866 | 01-15-2021 |
News, Short Squeeze, Breakout and More Instantly...
BriaCell Therapeutics Company Name:
BCTXF Stock Symbol:
OTCMKTS Market:
Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in combination with immune checkpoint inhibitors in advanced breast cancer will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2021, April 10-15 and May...
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 26, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (NASDAQ: BCTX, BCTXW) (“BriaCell” or the “Company”) , a clinical-stage biotechnology company specializing in targeted immunotherapies f...